| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.233 | 7.987 | 21.111 | 51.672 | 85.036 | 60.817 | - |
| Total Income - EUR | - | - | - | 4.233 | 7.987 | 21.111 | 51.672 | 96.061 | 79.275 | - |
| Total Expenses - EUR | - | - | - | 1.648 | 5.915 | 18.454 | 38.429 | 64.621 | 51.118 | - |
| Gross Profit/Loss - EUR | - | - | - | 2.585 | 2.071 | 2.656 | 13.243 | 31.440 | 28.157 | - |
| Net Profit/Loss - EUR | - | - | - | 2.490 | 1.991 | 2.400 | 12.788 | 30.621 | 27.561 | - |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Dragrup Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | - | - | - | 3.012 | 5.546 | 9.693 | 40.137 | 45.303 | 37.750 | - |
| Inventories | - | - | - | 0 | 0 | 0 | 487 | 833 | 831 | - |
| Receivables | - | - | - | 269 | 263 | 3.739 | 18.269 | 23.393 | 37.279 | - |
| Cash | - | - | - | 2.743 | 5.283 | 5.954 | 21.382 | 21.076 | -360 | - |
| Shareholders Funds | - | - | - | 2.533 | 4.475 | 6.790 | 19.428 | 30.845 | 27.601 | - |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | - | - | 479 | 1.071 | 2.903 | 20.709 | 14.458 | 10.148 | - |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
8810
|
|||||||||
Comments - Dragrup Medical S.r.l.